Publication | Closed Access

Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents

Tumor BiologyMedicinal ChemistryMedicineImmune Checkpoint InhibitorTumor TargetingAnti-cancer AgentNovel Isatin-based DerivativesPharmacologyRadiation OncologyNovel TherapyCancer ResearchDrug DiscoveryPotential Anticancer Agents